Home Vaccines Tags

View the Latest: Vaccines

Filter

List Grid

101-110 of 378 results

  • A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out

    Issue Brief

    As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of contracting COVID-19 as well as hard-to-reach groups, Medicaid agencies can be important partners for the public health agencies that are typically leading the state COVID-19 vaccination efforts. This brief provides…

  • Supply vs Demand: Which States are Reaching their COVID-19 Vaccine Tipping Points?

    Policy Watch

    This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

  • New Campaign from THE CONVERSATION / LA CONVERSACIÓN Responds to Information Needs about COVID-19 Vaccines Among Latinos and Spanish-speaking People in U.S.

    News Release

    News Release May 20, 2021 – THE CONVERSATION / LA CONVERSACIÓN expands to address information needs about the COVID-19 vaccines in the Latinx community with new videos featuring doctors, nurses and promotoras (community health workers) in English and Spanish. This installment of the campaign is produced by KFF (Kaiser Family Foundation) under its Greater Than COVID public information response and presented with UnidosUS. “THE CONVERSATION / LA CONVERSACIÓN campaign—and our efforts with the UnidosUS Esperanza Hope for…

  • The Last Major Phase of the COVID-19 Vaccination Roll-out: Children Under 5

    Issue Brief

    With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.

  • A Year of Vaccine Inequity

    Feature

    Just 7% of low-income countries' populations have received at least one dose of a COVID-19 vaccine as of December 20, well behind the 40% target for 2021.

  • Putting U.S. Global COVID-19 Vaccine Donations in Context

    Policy Watch

    While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country.  In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.

  • Tracking Global COVID-19 Vaccine Equity: An Update

    Issue Brief

    This updated analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries in Africa are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.